BACKGROUND: Transfusion-related immunomodulation (TRIM) encompasses immunosuppressive and proinflammatory effects induced by red blood cell (RBC) transfusion. Changes that occur during storage in the RBC product have been hypothesized to underlie TRIM, mediated by tolerance of toll-like receptors (TLR). We investigated whether transfusion of 35-day-stored autologous RBCs alters cytokine production in response to stimulation with lipopolysaccharide (LPS) or lipotheic acid (LTA), in a clinically relevant model of endotoxemia.
STUDY DESIGN AND METHODS:
Eighteen volunteers received 2 ng/kg LPS intravenously, followed by normal saline or 2-or 35-day-stored autologous RBC transfusion. Before LPS, before transfusion, and 6 hours after transfusion blood was collected to measure cytokine gene expression. Whole blood was used for ex vivo stimulation with LPS and LTA, after which cytokine levels were measured with enzyme-linked immunosorbent assay.
RESULTS:
In vivo LPS induced a biphasic response in cytokine mRNA with peak values 2 hours after LPS infusion. Storage time of RBC transfusion did not influence cytokine mRNA levels. In vivo infusion of LPS resulted in tolerance for ex vivo stimulation with LPS and LTA. However, transfusion of either fresh or stored RBCs did not further affect the capacity to produce cytokines after ex vivo stimulation.
CONCLUSION:
In a clinically relevant model of human endotoxemia, autologous transfusion of 35-day-stored RBCs does not influence cytokine mRNA levels nor does it change the capacity of white blood cells in whole blood to produce cytokines after ex vivo stimulation with LPS or LTA.
hemorrhaging. However, transfusion has also been related to serious to adverse events leading to increased morbidity and mortality, especially in critically ill patients. 1, 2 Several randomized trials suggest that a restrictive transfusion policy results in a better outcome than a liberal transfusion policy. 3 However, evidence on the deleterious properties of RBC transfusion is conflicting. In a set of heterogeneous trials (e.g., varying transfusion thresholds, patient populations, transfusion products) restrictive transfusion was associated with a reduced number of infectious complications, 4 even though no association could be found with mortality or overall morbidity 5 suggesting that transfusion-related immunomodulation (TRIM) may play a role. TRIM encompasses immunosuppressive and proinflammatory effects induced by RBC transfusion. The effect was first described in 1973 in a study demonstrating increased graft survival after renal transplantation in multiply transfused patients. 6 Other effects attributed to TRIM are the higher recurrence rates of cancer after transfusion and decreased recurrence of autoimmune diseases. 7 The factors in transfusion that mediate TRIM are unknown. The presence of donor white blood cells (WBCs) and time-dependent changes related to storage of blood products have been hypothesized to be related to TRIM. 7 Storage of RBCs induces the RBC "storage lesion," which results in declining product quality during shelf life. 8 The storage lesion has been implicated in transfusion-induced adverse events. 9, 10 In vitro storage of RBC units suppresses monocyte function 11, 12 but RBC transfusion has also been reported to enhance the release of danger signal highmobility group box 1 (HMGB1) in mice. HMGB1 can initiate and sustain the inflammatory response through tolllike receptor (TLR) 2 and TLR4, which supports the hypothesis that storage of RBCs has proinflammatory effects. 13 On the other hand, clinical studies that compared fresh products with standard time-stored products did not detect a decrease in mortality or morbidity after transfusion of fresh products. 14, 15 However, these studies did not investigate maximum storage time and other observational studies did report an effect of storage time. 16 Therefore, we investigated whether transfusion of maximum stored autologous RBCs results in immunomodulation in vivo. We used a randomized controlled trial in healthy volunteers to investigate the hypothesis that 35-day-stored autologous leukoreduced RBC transfusion would result in lipopolysaccharide (LPS) tolerance of TLR2 and TLR4 to respond to stimulation (tolerance) compared to 2-daystored autologous RBC transfusion. Among others, patients suffering from sepsis, 17 systemic inflammatory syndrome, 18 trauma, 19 and major surgery 20 also experience TLR LPS tolerance. Therefore, we used a model of human inflammation induced by intravenous (IV) injection of LPS to enhance translatability of our trial to clinical practice.
MATERIALS AND METHODS
All procedures have been reviewed and approved by the Academic Medical Center Medical Ethical Committee and are according to the Declaration of Helsinki including good clinical practice. The study has been registered at the Dutch Trial Register (NTR4455). All enrolled volunteers provided written informed consent before enrollment.
Subjects and design
This study is part of a larger study on the influence of storage time of RBCs on transfusion-related acute lung injury. 21 In short, a total of 18 healthy volunteers, ages 18 to 35 years old, were included in our open-label randomized controlled study. Volunteers were screened at the Academic Medical Center. To be included an unremarkable medical history as well as physical examination was required. Participants were not allowed to participate in another intervention trial during the course of our study.
Randomization and blood donation
Volunteers were randomly assigned into one of three groups: six volunteers received 2-day-stored (fresh) autologous RBC transfusion, six received 35-day-stored (stored) autologous RBC transfusion, and six volunteers were infused with 350 mL of 0.9% NaCl as endotoxemic control. Depending on group allocation, the volunteers donated 1 unit of blood 2 or 35 days before the study day. We used 35-day-stored products as shelf life has been maximized to 35 days in the Netherlands. Half of the endotoxemic control group donated 2 days before the study day, and the other half, 35 days before the experiment. The donated whole blood was processed to 1 unit of RBCs according to Sanquin protocols: whole blood (target volume, 500 mL) was collected in bottom-and-top systems with 70 mL of CPD and placed on butane-1,4-diol cooling plates until the following morning (16-22 hr ) and separated into a RBC unit, a unit of plasma, and a buffy coat of 50 6 5 mL with a hematocrit of 42 6 6% using a separator (CompoMat G5, Fresenius). SAG-M (110 mL) was added to the RBCs and the RBC product was leukoreduced by filtration, with remaining WBCs below 1 3 10 6 /unit. The products were cooled down to below 68C within 30 hours after collection and then stored in polyvinylchloride-diethyl-hexyl-phthalate containers at 2 to 68C for 2 or 35 days.
Experiment
On the day of the experiment, volunteers were admitted to the intensive care unit (Fig. 1) . At T 5 0 hours all volunteers received an infusion of 2 ng/kg LPS (National Institute of Health Clinical Center) as described before. [22] [23] [24] Two hours (T 5 2) after infusion of LPS the intervention group received an autologous transfusion of either "fresh" or "stored" RBCs. The experiment ended 8 hours after infusion of LPS. At this time point all LPS symptoms had abated and this time point corresponded with the harvesting of tissues in animal models in which a detrimental effect of transfusion was detected. 25, 26 The volunteers in the control group received an equivalent volume of saline (endotoxemic control). Arterial blood was collected in a lithium heparin-coated tube and in a tube (PAXgene, PreAnalytiX) at baseline (T 5 0 hours), 2 hours after infusion of LPS but before transfusion (T 5 2 hours), and 8 hours after infusion of LPS (T 5 8 hours). The PAXgene tubes were stored without any additional preprocessing at 2808C until further analysis.
Qualitative polymerase chain reaction
Whole blood in the PAXgene tubes was defrosted on a roller mixer and allowed to rotate for an additional 6 hours. RNA was isolated with the blood RNA kit (PAXgene, PreAnalytiX) according to the manufacturer's protocols. RNA yield was measured using a UV-Vis spectrophotometer (NanoDrop 2000, Thermo Scientific). cDNA synthesis was performed with equal RNA-input using a cDNA Synthesis During the study day healthy volunteers received LPS at T 5 0, followed by transfusion or saline infusion at T 5 2 and conclusion of the experiment at T 5 8. This was followed by stimulation of whole blood with LPS, LTA, or medium as control. In the final phase of the experiment ELISA and qPCR were performed to investigate cytokine responses.
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Kit (SensiFAST, Bioline), according to the manufacturer's protocols. Quantitative polymerase chain reaction (qPCR) was performed using a real-time PCR system (Lightcycler 480, Roche) with master mix (SensiFAST, Bioline) and 50 ng of primer (Sigma Aldrich). Intron spanning primer sequences and annealing temperatures are given in Table S1 (available as supporting information in the online version of this paper). Primer sequences for interleukin (IL)-8, IL-10, and tumor necrosis factor (TNF)-a were published previously.
27-29 Primer sequences for IL-1b, IL-6, and bactin were derived from the Harvard Primer Bank (PrimerBank IDs: 27894305c1, 224831235c1, and 4501885a1, respectively). The qPCR program was denaturation for 5 minutes at 958C, 45 to 55 cycles of 5 seconds at 958C, and 10 seconds of annealing at 658C, followed by 15 seconds at 728C. Quantification was performed using software (LinReg). The mean efficiency was calculated for each assay, and samples that had a deviation of more than 5% were excluded. Calculated values were normalized by the geometric mean of the reference gene values (b-actin and EF1a1).
Ex vivo stimulation
Ex vivo stimulation was used to investigate the effect of storage time of RBC transfusion on cytokine production in whole blood. All experiments were performed in duplicate. For the various time points, half a milliliter of heparinized whole blood was suspended in 0.5 mL RPMI-Lglutamine (Gibco, Thermo Fisher Scientific) in a sterile 24-well cell culture plate. The suspensions were stimulated ex vivo with 100 ng/mL LPS (Escherichia coli, O111:B4, ultrapure, Sigma), 10 mg/mL lipotheic acid (LTA; InvivoGen), or solely RPMI-L-glutamine as control as described. 17, 22 LPS is the endotoxin of Gram-negative bacteria and a TLR4 ligand. Similarly, LTA is major constituent of the cell wall of Gram-positive bacteria and ligand of the TLR2. We used LPS and LTA to investigate the hypothesis that stored transfusion products induce tolerance to these two TLR ligands. Cultures were incubated for 4 or 24 hours. After stimulation the samples were centrifuged (1500 3 g, 5 min, 48C) and the supernatant was stored at 2808C until further analysis.
Enzyme-linked immunosorbent assay
Standard sandwich enzyme-linked immunosorbent assays (ELISA) were used to quantify IL-1b, IL-6, IL-8, IL-10, TNF-a, and transforming growth factor (TGF)-b according to manufacturer's protocols (eBioscience). ELISA was performed on all samples of the stimulation assays and on the supernatant of the EDTA-anticoagulated samples. Two samples were included on each ELISA plate to account for interplate variability.
Supernatants from ex vivo stimulated WBCs in whole blood, incubated with LPS or LTA for 4 or 24 hours, were analyzed in batch after completion of the study. The pattern in 4-hour stimulated WBCs in whole blood was similar to 24-hour stimulations. We therefore only present the data from 24-hour-stimulated samples in this article.
Power calculation
This study was a secondary investigation of a study on the effect of transfusion on pulmonary function and was initially powered to detect differences in pulmonary inflammation. 21 We performed a second power calculation to investigate whether it could also be used to investigate the effect of transfusion on ex vivo stimulation with LPS. We based our calculations on a previous publication that investigated the effect of RBC storage time on cytokine production by monocytes in vitro. In this study TNF-a was 48,525 6 7832 pg/mL in controls. Stored RBCs decreased monocyte TNF-a production approximately 50% with a standard deviation (SD) of 7.5%. 12 Based on these numbers we needed to include four volunteers to detect a similar signal with an alpha of 0.005 and a beta of 0.90. However, in vivo studies usually result in smaller differences. We therefore also calculated the smallest detectable effect. With six volunteers, an alpha of 0.05, and a beta of 0.80 we are able to detect a difference of 15% between our groups with a SD of 9%.
Statistical analysis
Data were inspected for normality using histograms and density plots. As this inspection showed no Gaussian distributions we used a Wilcoxon sign rank test to compare T 5 0 (baseline) with T 5 2 (pretransfusion) and to compare cytokines levels after LPS or LTA incubation with the negative control. Differences at T 5 8 (posttransfusion) and the delta between T 5 2 and T 5 8 between treatment groups were investigated with a Kruskal-Wallis test. All statistical analyses were performed in computer software (R Version 3.1.2, R-core team). Double-sided p values of less than 0.05 were considered to be significant. As this was considered an explorative study, we did not correct for multiple testing. Samples with values below the detection limit of the assay were expressed as equivalent to the detection limit and compared to expression as equivalent to 0. This did not change the results of our study and therefore we used expression as equivalent to the detection limit for all statistical analyses.
RESULTS
We screened 22 volunteers and included 18 subjects all of whom completed the study according to protocol. The participants had the expected response to LPS and developed tachycardia, decreased blood pressure, tachypnea, and fever 1.5 hours after infusion. Symptoms abated 8 hours after infusion. Laboratory measurements at the routine clinical laboratory showed leukocytosis. 21 
Transfusion of 35-day-stored RBCs does not result in changed cytokine gene expression in unstimulated blood
We first investigated whether transfusion of stored RBCs influenced the level of cytokines proteins in plasma after IV LPS challenge. These were samples collected from the healthy volunteers and analyzed for cytokine levels in the plasma without any additional ex vivo stimulation. All cytokines followed a typical biphasic pattern as expected after LPS infusion but storage time of RBCs did not change the levels compared to fresh RBCs or saline infusion (data previously published in Fig. S1 , available as supporting information in the online version of this paper). 21 We then investigated whether transfusion of stored RBCs affected cytokine gene expression in these samples. LPS induced a biphasic response in IL-1b, IL-8, and TNF-a mRNA with peak values 2 hours after LPS infusion (p < 0.0001, p < 0.0001, and p < 0.05 for IL-1b, IL-8, and TNF-a, respectively; Fig. 2 ). IL-6 mRNA levels did not change during the experiment in accordance with a previously published report, 30 and IL-10 increased gradually with maximum levels at T 5 8 (p < 0.01 T 5 8 compared to T 5 0; Fig. 2 ). In summary, LPS infusion resulted in a LPS-typical biphasic pattern, but no influence of the transfusion of stored or fresh RBCs was seen on pro-or anti-inflammatory cytokine protein and gene levels.
LPS results in LPS tolerance
In vivo LPS infusion leads to tolerance to ex vivo stimulation of whole blood with TLR ligands, a phenomenon known as LPS tolerance. 31 We first confirmed that volunteers developed LPS tolerance during endotoxemia. Samples obtained at T 5 0 were collected before in vivo infusion of LPS. At T 5 0 ex vivo incubation with LPS or LTA resulted in release of IL-1b, IL-6, IL-8, IL-10, TNF-a, and TGF-b compared to incubation in medium alone (p < 0.001 for all cytokines for both LPS and LTA; Fig. 3 ). At T 5 2, 2 hours after in vivo infusion of LPS, IL-1b, IL-6, IL-8, IL-10, and TNF-a did not reach the detection limit of the assays in most samples (p < 0.0001 compared to T 5 0; Fig. 3 ), indicative of a clear reduced response to stimulation with LPS and LTA during endotoxemia. LTA stimulation had a similar, although less pronounced, effect (IL-1b p < 0.05, IL-6 p < 0.0001, IL-8 no change, IL-10 p < 0.01, and TNF-a p < 0.01; Fig. 3 ). TGF-b levels were not affected by LPS and LTA.
Transfusion of stored RBCs does not alter the ex vivo response of whole blood to LPS or LTA compared to transfusion of fresh RBCs or endotoxemic control
After establishing that in vivo LPS resulted in LPS tolerance, we investigated whether stored RBC transfusion influenced the response of whole blood to ex vivo stimulation with LPS and LTA compared to transfusion of fresh RBCs or saline infusion. At T 5 8, 8 hours after in vivo LPS-infusion and 6 hours after transfusion of fresh or stored RBCs, cytokine levels returned to baseline in the ex vivo stimulation experiments. We compared the increment in cytokine levels in each group from T 5 2 to T 5 8 and compared the levels between the three groups at T 5 8 to establish the influence of RBC transfusion. Ex vivo stimulation with LPS did not result in changed cytokine levels between transfusion of stored RBCs, transfusion of fresh RBCs, or endotoxemic control at T 5 8. The increment from T 5 2 to T 5 8 also did not differ between the intervention groups. Stimulation with LTA produced similar results. We did not detect any differences in cytokine expression between T 5 2 and T 5 8, nor did the groups differ at T 5 8 (Fig. 3) . However, although the difference did not reach significance, IL-6 response to LTA stimulation appeared to be reduced in the stored group with a concurrent decrease in IL-8 response (Figs. 3B and  3C ). As the responses of IL-6 and IL-8, which are both proinflammatory, go in opposite directions and the results from 4-hour stimulations did not show similar patterns in these ex vivo stimulations (data not shown), we concluded that these are a result of assay variation.
DISCUSSION
In this study we investigated the effect of storage time of RBC transfusion products on the response of whole blood on ex vivo stimulation with LPS and LTA in a human model of endotoxemia. We found that 1) transfusion of 35-day-stored RBCs does not result in changed cytokine gene expression compared to fresh RBCs, 2) LPS results in LPS tolerance, and 3) transfusion of stored RBCs in vivo does not result in altered cytokine levels after ex vivo stimulation of whole blood compared to transfusion of fresh RBCs or endotoxemic control. The patterns of cytokine expressions we detected after in vivo exposure to LPS, and additional stimulation with LPS or LTA ex vivo, are in accordance with other investigations with human endotoxemia. [30] [31] [32] However, our data argue against our hypothesis that transfusion of stored RBCs alters the response of whole blood to additional ex vivo stimulation with LPS or LTA. In our study, the cytokine levels before and after ex vivo stimulation were similar in all three groups. This is not in line with previous studies. In vitro stored RBCs induce immunosuppression in whole blood and isolated monocytes stimulated with LPS. 11, 33, 34 Moreover, in pediatric intensive care patients transfusion of stored RBCs was found to result in lower TNF-a production after ex vivo LPS stimulation of whole blood compared to transfusion of fresh RBCs. 35 There are several explanations for our findings. First, it is possible that children are more susceptible to the effects of RBC storage time than adult patients. However, it is also possible that the adverse effects that have been attributed to stored transfusion products have been overestimated. The evidence that transfusion of products with increased storage time can have detrimental effects is largely derived from observational studies which report conflicting evidence. 9 The pediatric study may have suffered from its observational design: the decision to transfuse in this study was made by the treatment team, which may have resulted in inclusion bias. 35 Moreover, several recent randomized controlled trials that investigated the effect of RBC storage time on morbidity and mortality did not detect any detrimental effects of longer RBC shelf life both in adult and pediatric patients. 14, 15, 36 Another explanation for our findings may be that both in vitro studies and in vivo studies that report a harmful effect of storage time have made use of allogeneic products. It is possible that interactions between donor and recipient and the use of animals and in vitro techniques, and not storage time, are responsible for the effects detected in these studies. [11] [12] [13] 35, 37 Indeed, several autologous human volunteer studies did not detect a role for storage time in the pathogenesis of transfusion-related adverse effects. 38, 39 These studies investigated RBC storage time in healthy volunteers, which limits comparability to clinical practice. However, in this study we were able to overcome this limitation by using LPS endotoxemia as a model for sepsis and still were not able to confirm the hypothesis that stored RBCs have immunomodulatory effects. Our results may also have been influenced by RBC production and storage techniques. The quality of RBCs during storage is influenced by production protocols and storage solutions. [40] [41] [42] [43] [44] There is limited evidence of what the effect is of these different techniques on RBC function, but in vitro studies indicated that storage solution influences immunomodulatory effect of stored RBCs. 12 Another factor that can influence transfusion product quality are donor-related factors. Increasing evidence indicates that donor genetic traits and lifestyle can influence product quality and perhaps also mediate adverse effects of transfusion. 45 The fact that we only included healthy volunteers might thus even have led to a "donor bias." It is also possible that the RBC transfusions have immunomodulatory effects that cannot be detected by investigating response to ex vivo stimulation of whole blood with LPS or LTA. An in vitro study detected changed expression of TLR4 gene expression in WBCs after exposure of whole blood to stored RBCs. 46 In another study healthy volunteers received a stored autologous transfusion to investigate diagnostic techniques to detect autologous blood doping. In this study proteomics revealed increased expression of TLR4, TLR5, and TLR6 in T lymphocytes. 47 HLA-DR expression is another potentially interesting marker. HLA-DR is an antigen presenting molecule that is expressed by monocytes. During immunoparalysis in, for example, sepsis but also LPS endotoxemia, monocyte HLA-DR is down regulated. 48, 49 It may be worthwhile to use these techniques to investigate the effect of transfusion in patients or in endotoxemia. Our study has several limitations. First, we used an autologous transfusion model. Although this facilitated investigation of the isolated effect of storage time, it decreases comparability with clinical practice. Moreover, it cannot be excluded that storage time and allogeneic properties of the transfusion product have synergistic effects and that stored allogeneic products thus are able to induce adverse effects.
Another limiting factor is that we sampled blood up to 8 hours after LPS infusion, corresponding to 6 hours after transfusion. It is possible that this time window was too short to detect an effect of the interventions. Although most studies showed an effect within 6 hours of transfusion, in an earlier study in which healthy volunteers received a stored autologous transfusion, blood was sampled after 72 and 96 hours. In these samples down regulation of lymphocyte TLR was detected accompanied by an adaptive immune response. 47 This study did not investigate time points before 72 hours after transfusion and we cannot exclude that sampling later than 8 hours after LPS infusion in our study would have resulted in evidence supporting immunomodulation. In our study we used whole blood for ex vivo stimulation with LPS or LTA. However, it is possible that different types of WBCs behave differently in response to transfusion or that responsive immune cells reside outside the blood stream (e.g., spleen or liver). These cells cannot be investigated with stimulations of whole blood. It may be worthwhile if future studies investigate the effect of RBC transfusion on subsets of immune cells, instead of whole blood.
Finally we cannot exclude that a more potent inflammatory state is required to be susceptible for RBC-induced immunomodulation. LPS endotoxemia does not equal sepsis, even though LPS infusion successfully induced systemic inflammatory response syndrome in our healthy volunteers. It is possible that more severe disease, including noninfectious pathology, activates other inflammatory pathways in which the patient is susceptible for immunomodulation by transfusion. Moreover, our healthy volunteers did not suffer from anemia during our study. We were thus not able to investigate whether anemia alters the response to RBC transfusion.
In conclusion, we investigated whether transfusion of 35-day-stored RBCs changed cytokine mrRNA levels or induced tolerance of the TLR2 or TLR4 for stimulation in a human autologous transfusion model of endotoxemia. Storage time of RBC transfusion did not influence cytokine mRNA levels nor did it affect the reaction of TLR2 or TLR4 to stimulation with LPS or LTA. In our healthy human volunteer autologous transfusion study, transfusion of stored RBCs did not affect cytokine production after ex vivo LPS stimulation. 
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